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Abstract This study focused on the variations in phosphoinosi- 
tide metabolism depending upon tXllb[i3-integrin/fibrinogen i ter- 
action without previous activation of platelet agonist receptors. 
We found that adhesion of resting human platelets to immobi- 
lized fibrinogen stimulates phosphatidic acid production and a 
concomitant decrease in phosphatidylinositol 4',5'-bisphosphate. 
These results, and the absence of a transphosphatidylation 
reaction, argue in favor of the activation of a phospholipase C. 
Moreover, we observed the accumulation of phosphatidylinositol 
3',4'-bisphosphate in adherent platelets as a consequence of the 
activation of a phosphatidylinositol 3-kinase. This effect was 
inhibited by ADP scavengers. Our results demonstrate that in 
adherent platelets, whereas phosphatidylinositol 3-kinase activa- 
tion is controlled by both Ctlib~integrin engagement and released 
ADP, phospholipase C stimulation is triggered only by O~ilb~- 
integrin/fibrinogen interaction. 
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1. Introduction 
Integrin aiib[3a is a well-known receptor for adhesive pro- 
teins responsible for platelet aggregation and adhesion to 
damaged vessel walls, therefore playing an important role in 
primary hemostasis. The main ligand of aIIb]33 is fibrinogen 
which, in soluble form, is bound only after previous activation 
of aHb[3a-integrin. One dodecapeptide s quence at the carbox- 
yl terminus of the fibrinogen T-chain is primarily involved in 
both platelet aggregation and adhesion [1-3]. The integrin 
anb~a does not display any intrinsic enzymatic activity (re- 
viewed in [4]) but associates in vivo or in vitro with signaling 
enzymes uch as p60 C-s'c and p125 FAK [5,6]. Data on the 
signaling pathway depending upon aIIb[33 activation in plate- 
lets have greatly enhanced knowledge of integrin-mediated 
signal transduction. Inhibition of fibrinogen binding to 
Cqib[33 in stimulated platelets has highlighted the role of this 
glycoprotein i regulating a number of signals including cyto- 
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plasmic alkalinization [7], calcium influx [8], and protein-tyr- 
osine phosphorylation [9]. 
We have previously demonstrated that the inhibition of 
fibrinogen binding to  O~iib[~ 3 inhibits the synthesis of the major 
phosphatidylinositol 3',4'-bisphosphate (PtdIns(3,4)P2) pool 
in thrombin-stimulated platelets [10]. D3-phosphorylated 
phosphoinositides are involved in the phosphorylation of 
pleckstrin [11-13] and in the activation of the receptor func- 
tion of CtHbB3-integrin [14] in platelets, and in mitogenesis or 
cell transformation i  nucleated cells [15,16]. Finally, D3- 
phosphorylated phosphoinositides could regulate different 
events, such as activation of specific isoforms of protein ki- 
nase C, cytoskeleton organization, or intracellular trafficking 
[17]. 
In order to study signal transduction via the phosphoinosi- 
tide pathway depending upon tXiib[33-integrin function without 
previous activation of other agonist receptors, we took advan- 
tage of the property of resting aiib~la-integrin mediating cell 
adhesion to immobilized fibrinogen. This type of interaction 
has clinical relevance as it could occur during platelet-extra- 
cellular matrix, and platelet-platelet interactions in vivo. Data 
obtained by Haimovich et al. [18] after adhesion of platelets to 
immobilized fibrinogen have shown that tyrosine phosphory- 
lation of specific proteins was triggered by anb~la/fibrinogen 
interaction accompanying platelet spreading. Moreover, some 
of these tyrosine phosphorylation steps may be under the 
control of p125 FAn [18]. 
In this study, we investigated phosphoinositide metabolism 
in human platelets adherent on a matrix of fibrinogen. We 
show: (1) the stimulation of a phospholipase C during the 
early stages of the adhesion process; and (2) slower synthesis 
of PtdIns(3,4)P2 in adherent platelets involving ADP released 
upon adhesion. These results outline similarities in changes of 
phosphoinositide metabolism triggered by integrins and ago- 
nist receptors. 
2. Materials and methods 
2.1. Reagents 
Human flbrinogen, ADP, apyrase, pyruvate kinase, phosphoenol- 
pyruvate, fatty acid free-BSA, and PBS were from Sigma (Sigma 
Chemical Co., St. Louis, MO). 
2.2. Preparation of platelets 
Human platelets were isolated from fresh platelet concentrates 
(Centre R6gional de Transfusion Sanguine, Toulouse, France) by cen- 
trifugation as already described [19]. In some experiments, platelet- 
rich plasma was incubated with 100 I.tM aspirin for 20 min to block 
cyclooxygenase activity. All washing procedures were performed 
at 37°C in the presence of apyrase (1 U/ml) as ADP scavenger. Label- 
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ing of platelets was performed for 90 min with 0.4 mCi/ml 
[y-a2P]phosphate (Amersham, Ltd. Bucks, UK) as previously de- 
scribed [19]. Platelets were finally resuspended in modified Tyrode's 
buffer (pH 7.4) containing 2.5 mM CaC12. 
2.3. Cell adhesion assay 
Cell culture flasks (75 cm 2, CEB, Angers, France) were precoated 
for 16 h at 4°C with 100 gg/ml of fibrinogen within 20 ml of Tyrode's 
buffer without BSA. Control flasks were treated according to the same 
protocol but without adhesive protein. After three washes with Tyr- 
ode's buffer without BSA, fibrinogen-coated and control flasks were 
blocked for 3 h at 4°C with fatty acid free-BSA (10 mg/ml; 20 ml) in 
order to decrease non-specific platelet adhesion to polystyrene. Prior 
to the adhesion assay, flasks were washed three times with Tyrode's 
buffer without BSA. 
The cell adhesion assay was performed using 10 ml of human plate- 
lets (3 x l0 T platelets/ml) that were added for 5-30 min at 37°C to the 
fibrinogen-coated or control flasks. 6-24 flasks were used to recover 
sufficient numbers of platelets allowing measurement of the D3-phos- 
phorylated phosphoinositides by HPLC. In some experiments, the 
ADP scavenger pyruvate kinase plus phosphoenolpyruvate (14.3 U/ 
ml and 1 mM, respectively) was added to the platelet suspension for 
10 min before adhesion. At the end of the experiment, non-adherent 
platelets were removed by aspiration. Flasks were then washed twice 
with PBS. The extent of cell adhesion was evaluated both by counting 
the remaining non-adherent platelets and by comparison of the total 
radioactivity incorporated into the lipid fraction from non-adherent 
and adherent platelets. 
2.4. Lipid extraction and analysis 
Adherent platelets were rapidly scraped off in the presence of 
CHzOH/EDTA (8 mM) and immediately transferred into CHC13. 
Lipids from adherent and non-adherent cells were extracted as pre- 
viously described [19]. Lipids were then deacylated by methylamine 
treatment, and separated by HPLC on a Partisphere SAX column 
(Whatman International Ltd., UK) using an elution gradient of 0-1 
M ammonium phosphate as previously described [19]. Radioactivity 
was detected on line with a Berthold LB506C radioactivity monitor. 
3. Results 
3.1. Stimulation of  PLC  and Ptdlns 3-kinase activities upon 
platelet adhesion to a fibrinogen matrix 
As previously reported [1,20], we found that unstimulated 
platelets adhered to, and spread on a fibrinogen-coated poly- 
styrene surface. In our experiments, platelets adhered primar- 
ily as single cells without forming aggregates. No platelet ad- 
hesion to control flasks was observed. Adhesion of platelets to 
fibrinogen-coated flasks was time-dependent, increasing from 
0.5× 107 to 2× 107 and 3× l07 platelets/flask after 5, 15, and 
30 min of incubation, respectively. After 15 min of incubation, 
an increase in [32P]phosphatidic acid (PtdOH) (288+71%), 
and a decrease in [z2P]Ptdlns(4,5)P2 (39+ 5%) in adherent 
platelets were observed (Fig. 1). As shown in Fig. 2A, max- 
imal increase in [aeP]PtdOH production was observed as early 
as 5 min of adhesion. At the same time, maximal decrease in 
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Fig. 1. Effect of platelet adhesion to immobilized fibrinogen on 32p 
labeling of various phosphoinositides. Platelets were incubated for 
15 min in flasks coated with fibrinogen or albumin (control). Adher- 
ent platelets from fibrinogen-coated flasks (solid bars) and non-ad- 
herent ones from control flasks (open bars) were recovered and their 
lipids extracted as described in Section 2. 32p radioactivity incorpo- 
rated into various phosphoinositides is expressed in cpm from 10 s 
platelets and data are means + S.E.M. from 9 independent experi- 
ments. Radioactivity of [32p]Ptdlns(3,4)P2 was undetectable in sam- 
ples of non-adherent platelets and is not represented. Significance of 
adhesion-induced variations of platelet PtdOH and Ptdlns(4,5)P2 
was calculated with the Student's t-test: ***p < 0.001 ; **p < 0.01. 
[a2P]Ptdlns(4,5)P2 was measured (Fig. 2A). Thereafter, these 
two metabolites returned gradually to a new plateau. Thus, 
our results suggest that a phospholipase active on 
Ptdlns(4,5)P2 is rapidly and transiently stimulated in adherent 
platelets. PtdOH could come either from a PLC/diglyceride 
kinase or a PLD. Transphosphatidylation is an exclusive 
property of PLD that produces phosphatidylethanol (PEt) 
instead of PtdOH in the presence of ethanol. We assessed 
the formation of [32p]PEt within labeled platelets added to 
the fibrinogen-coated flask in the presence of 0.5% ethanol. 
After lipid extraction, separation by TLC and autoradiogra- 
phy, [z2p]PEt was not detected in adherent platelets (data not 
shown). Thus, our results indicate the activation of a PLC 
promoted by platelet adhesion to immobilized fibrinogen. 
We also observed that [Z2P]Ptdlns(3,4)P2, which was undetect- 
able in control platelets, was synthesized in adherent platelets 
(Fig. 1). Synthesis of this phosphoinositide 3-kinase (Ptdlns 3- 
kinase) product was time-dependent (Fig. 2B) and represented 
an average of 10% of total the [32P]PtdlnsP2 level 
(Ptdlns(3,4)P2+Ptdlns(4,5)P2). Beside the variations in PtdOH 
and Ptdlns(3,4)P2, no significant change of 32p incorporation 
into Ptdlns, Ptdlns(3)P, Ptdlns(4)P and Ptdlns(3,4,5)P3 was 
observed in adherent platelets (Fig. 1). 
Table 1 
Consequences of platelet reatment with ADP scavenger or cyclooxygenase inhibitor on [32P]PtdOH and [z2P]Ptdlns(3,4)P2 production upon ad- 
hesion 
[azP]PtdOH (cpm) [32P]PtdIns (3,4)P2 (cpm) 
Control Adherent ceils Control Adherent cells 
No treatment (n = 5) 844 + 273 2048 + 641 N.D. 333 + 141 
PK-PEP (n = 3) 1409 + 69 3364 + 624 N.D. traces 
Aspirin (n = 2) 700 + 51 2450 + 362 N.D. 358 + 30 
Treatment of platelets and measurement of [32P]PtdOH and [a2P]Ptdlns(3,4)P2 were performed as described in Section 2. cpm of [a2P]PtdOH and 
[a2p]Ptdlns(3,4)P2 are from 108 platelets (mean + S.E.M.) after 30 min of adhesion to a fibrinogen matrix. In the control platelets, [a2p]Ptdlns(3,4)P2 
was not detectable (N.D.) under our experimental conditions. The number of experiments (n) is indicated on the table. 
D. Gironcel et al./FEBS Letters 389 (1996) 253-256 255 
3.2. ADP is involved in adhesion-dependent Ptdlns 3-kinase 
activation 
ADP present in dense granules and cyclooxygenase prod- 
ucts (TXA2) released after platelet activation are platelet ago- 
nists. Since Haimovich et al. [18] have suggested that small 
amounts of ADP could be released by adherent platelets, we 
performed a platelet adhesion assay in the presence of pyru- 
vate kinase plus phosphoenolpyruvate s an ADP scavenger 
system. The number of adherent platelets recovered on the 
fibrinogen matrix was not significantly changed by this treat- 
ment. Whilst the [32P]PtdOH increase triggered by adhesion 
was unchanged, the production of [32p]Ptdlns(3,4)P2 was 
hardly measurable in adherent platelets that had been treated 
with ADP scavenger (Table 1). Moreover, the addition of 
ADP (20 ~tM) to adherent platelets after removing the ADP 
scavenger resulted in the recovery of [32p]Ptdlns(3,4)P2 prod- 
uction: in two independent experiments he [32p]Ptdlns(3,4)P2 
level increased from a trace amount to 144 and 740 cpm, 
respectively, for 108 adherent platelets after 30 min of treat- 
ment by ADP. As a control, adherent platelets that were not 
incubated with ADP did not produce Ptdlns(3,4)P2. On the 
other hand, treatment of platelets with aspirin in order to 
inhibit cyclooxygenase activity and TXA2 production modi- 
fied neither PtdOH nor Ptdlns(3,4)P2 production upon plate- 
let adhesion (Table 1). These results uggest that ADP but not 
TXA2 is involved in adhesion-dependent Ptdlns(3,4)P2 syn- 
thesis. 
4. Discussion 
The aim of this study was to determine modifications of 
phosphoinositide metabolism promoted by direct aiib[~3-integ- 
rin/fibrinogen i teraction without previous activation of plate- 
lets by other agonists. Since aiib133-integrin  resting platelets 
is able to recognize immobilized fibrinogen, we used a platelet 
adhesion assay on fibrinogen-coated flask to measure 32p in- 
corporation into phosphoinositides. 
We showed for the first time that a PLC could be activated 
secondary to platelet adhesion to a fibrinogen matrix. Indeed, 
we measured the synthesis of PtdOH concomitantly with the 
decrease in PtdIns(4,5)P2 in platelets adherent on a fibrinogen 
matrix. Moreover, we did not detect PEt as a consequence of
PLD activation in adherent platelets. These results, together 
with the facts that PtdOH is the most sensitive indicator of 
PLC activity [21,22] and that PLD-dependent PtdOH forma- 
tion is negligible in fully activated platelets [23], are in favor of 
PLC activation dependent on aiibl3a-integrin engagement. 
Other integrins have been shown to regulate PLC activity: 
PLC-y1 and G-protein coupled PLC in LFA-1 and avl3a-in- 
tegrin-dependent signaling, respectively [24,25]. We are cur- 
rently performing experiments to identify the PLC isoform 
involved in our model. 
The second signal evoked upon platelet adhesion to a fibri- 
nogen matrix is PtdIns 3-kinase activation. Indeed, we have 
measured in adherent platelets an increase in PtdIns(3,4)P2. 
Even though PtdIns(3,4)P2 synthesis in platelets could be un- 
der the possible control of three enzymes (PtdIns(4)P 3-kinase, 
PtdIns(3)P 4-kinase, PtdInsP3 5-phosphatase), in all cases a 
PtdIns 3-kinase must be stimulated. This result is of impor- 
tance as we have demonstrated that the physiological integrin/ 
ligand interaction is able to stimulate PtdIns 3-kinase without 
previous cell activation by other agonists. In agreement with 
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Fig. 2. Time course of 32p-labeled PtdOH, Ptdlns(4,5)P2 (A) and 
Ptdlns(3,4)P2 (B) upon platelet adhesion to a fibrinogen matrix. 
Platelets were allowed to adhere to a fibrinogen matrix for the indi- 
cated times and then lipids were extracted as described in Section 2. 
32p radioactivity of phospholipids i expressed in cpm from 108 
platelets. Data are from one experiment representative of three that 
gave similar results. 
our results, Kovacsovics et al. [14], using anti-anb~3 mono- 
clonal antibodies, have recently shown that PtdIns 3-kinase 
activation is involved in the signal transduction pathway from 
activated anbl3z-integrins. 
We have demonstrated here that ADP is involved in the 
major part of the PtdIns 3-kinase activation in adherent plate- 
lets to a fibrinogen matrix. Haimovich et al. [18,26] have 
shown that ADP, and a protein kinase C activated own- 
stream, are involved in p125 FAK tyrosine phosphorylation 
upon platelet adhesion to a fibrinogen matrix, p125 FAK, a 
protein-tyrosine kinase found in focal adhesion sites and acti- 
vated after Ctlib[331fibrinogen binding [27], coimmunoprecipi- 
tares with PtdIns 3-kinase in thrombin-stimulated platelets 
and binds in vitro to the SH3 domain of the regulatory sub- 
unit p85c~ of the PtdIns 3-kinase [28]. This association is suffi- 
cient to stimulate PtdIns 3-kinase activity [28]. Thus, upon 
platelet adhesion to a fibrinogen matrix, the ADP-dependent 
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Ptdlns 3-kinase activity could be regulated by p125 FAg, or, 
the Ptdlns 3-kinase products could be necessary for the acti- 
vation of the PKC involved in p125 FAn stimulation. 
The results of this study delineate an activation pathway 
after adhesion of unstimulated platelets which could be of 
relevance in physiological hemostasis as well as cardiovascular 
diseases, and offers an excellent model to study the relation- 
ship between phosphoinositide metabolism and platelet mor- 
phological changes occurring in these processes. 
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